DK0705298T3 - Albuminbaseret hydrogel - Google Patents

Albuminbaseret hydrogel

Info

Publication number
DK0705298T3
DK0705298T3 DK95901297T DK95901297T DK0705298T3 DK 0705298 T3 DK0705298 T3 DK 0705298T3 DK 95901297 T DK95901297 T DK 95901297T DK 95901297 T DK95901297 T DK 95901297T DK 0705298 T3 DK0705298 T3 DK 0705298T3
Authority
DK
Denmark
Prior art keywords
novel
hydrogels
novel hydrogels
albumin
bifunctionalyzed
Prior art date
Application number
DK95901297T
Other languages
Danish (da)
English (en)
Inventor
Guy Fortier
Original Assignee
Bioartificial Gel Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioartificial Gel Technologies Inc filed Critical Bioartificial Gel Technologies Inc
Application granted granted Critical
Publication of DK0705298T3 publication Critical patent/DK0705298T3/da

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
DK95901297T 1993-12-01 1994-11-24 Albuminbaseret hydrogel DK0705298T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15955993A 1993-12-01 1993-12-01
PCT/CA1994/000650 WO1995015352A1 (en) 1993-12-01 1994-11-24 Albumin based hydrogel

Publications (1)

Publication Number Publication Date
DK0705298T3 true DK0705298T3 (da) 2002-07-08

Family

ID=22573064

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95901297T DK0705298T3 (da) 1993-12-01 1994-11-24 Albuminbaseret hydrogel

Country Status (9)

Country Link
US (1) US5733563A (es)
EP (1) EP0705298B1 (es)
AT (1) ATE215106T1 (es)
AU (1) AU1060495A (es)
DE (1) DE69430243T2 (es)
DK (1) DK0705298T3 (es)
ES (1) ES2172573T3 (es)
PT (1) PT705298E (es)
WO (1) WO1995015352A1 (es)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583114A (en) * 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
US6004583A (en) * 1995-03-22 1999-12-21 Orex Pharmaceutical Development Corp. Protein-containing polymer composition for oral administration
JP3145409B2 (ja) * 1995-03-24 2001-03-12 フォーカル， インコーポレイテッド 活性酸素阻害剤の制御送達を用いる癒着の低減
US5786439A (en) * 1996-10-24 1998-07-28 Minimed Inc. Hydrophilic, swellable coatings for biosensors
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7883693B2 (en) * 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
AU717660B2 (en) * 1995-12-18 2000-03-30 Angiodevice International Gmbh Crosslinked polymer compositions and methods for their use
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
IL118848A0 (en) * 1996-07-14 1996-10-31 Univ Bar Ilan Method for preparing bioactive polymers
ATE264693T1 (de) * 1996-08-02 2004-05-15 Orex Pharmaceutical Dev Corp Polymerzusammensetzung zur oralen administration von peptiden und proteinen
US6011110A (en) * 1996-09-13 2000-01-04 Nisshinbo Industries, Inc. Carrier for bioreactor and method of producing the same
US6743248B2 (en) 1996-12-18 2004-06-01 Neomend, Inc. Pretreatment method for enhancing tissue adhesion
US20040176801A1 (en) * 1997-03-12 2004-09-09 Neomend, Inc. Pretreatment method for enhancing tissue adhesion
US20030191496A1 (en) * 1997-03-12 2003-10-09 Neomend, Inc. Vascular sealing device with microwave antenna
US6371975B2 (en) 1998-11-06 2002-04-16 Neomend, Inc. Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
US6872384B1 (en) 1998-02-23 2005-03-29 Life Medical Sciences, Inc. Treatment of trauma
US7179487B1 (en) * 1998-06-19 2007-02-20 University Of Utah Research Foundation Hydrogels of water soluble polymers crosslinked by protein domains
US6994686B2 (en) 1998-08-26 2006-02-07 Neomend, Inc. Systems for applying cross-linked mechanical barriers
US6458147B1 (en) 1998-11-06 2002-10-01 Neomend, Inc. Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue
CA2344675A1 (en) 1998-09-22 2000-03-30 The Procter & Gamble Company Personal care compositions containing active proteins tethered to a water insoluble substrate
US7279001B2 (en) * 1998-11-06 2007-10-09 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US6949114B2 (en) 1998-11-06 2005-09-27 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US6830756B2 (en) * 1998-11-06 2004-12-14 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US6899889B1 (en) * 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US7351249B2 (en) * 1998-11-06 2008-04-01 Neomend, Inc. Systems, methods, and compositions for achieving closure of suture sites
DE19903655A1 (de) 1999-01-29 2000-08-10 Beiersdorf Ag Proteinhaltige Hydrogele
AU5207099A (en) 1999-02-23 2000-09-14 Phairson Medical Inc. Treatment of trauma
US6303119B1 (en) 1999-09-22 2001-10-16 The Procter & Gamble Company Personal care compositions containing subtilisin enzymes bound to water insoluble substrates
KR20020073156A (ko) * 1999-12-30 2002-09-19 헨더슨 몰리 리서치 앤드 디벨럽먼트 리미티드 Ｄｎａ 바이러스 감염의 시너지 치료
US7039453B2 (en) * 2000-02-08 2006-05-02 Tarun Mullick Miniature ingestible capsule
JP5154726B2 (ja) 2000-02-17 2013-02-27 ネオメンド，インコーポレイティド 予備成形された生分解性ポリマー組成物を使用したデリバリシステムおよび方法
JP2003523409A (ja) * 2000-02-25 2003-08-05 デイビッド シエラ 泡形成創傷被覆剤
US6627785B1 (en) * 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
DE60122500T2 (de) * 2000-04-04 2007-05-03 Bioartificial Gel Technologies Inc., Montreal Verfahren zur herstellung von proteinhaltigen hydrogelen
CA2409188A1 (en) * 2000-05-30 2001-12-06 Viridis Biotech Inc. Polyubiquitin based hydrogel and uses thereof
WO2002016557A2 (en) * 2000-08-21 2002-02-28 Rice University Tissue engineering scaffolds promoting matrix protein production
JP4373092B2 (ja) * 2001-03-08 2009-11-25 バイオアーティフィシャル・ゲル・テクノロジーズ・インコーポレーテッド 支持体に結合したヒドロゲルおよびその製造方法
US7037895B2 (en) * 2001-03-27 2006-05-02 Medical College Of Ohio Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
US7605130B2 (en) * 2002-03-26 2009-10-20 Medical College Of Ohio Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
CA2457876C (en) 2001-08-22 2011-10-11 Bioartificial Gel Technologies Inc. Process for the preparation of activated polyethylene glycols
US6783721B2 (en) * 2001-10-30 2004-08-31 Howmedica Osteonics Corp. Method of making an ion treated hydrogel
WO2003046144A2 (en) * 2001-11-26 2003-06-05 Molecular Reflections, Inc. Microscale immobilization of molecules using a hydrogel and methods of use thereof
US20050124062A1 (en) * 2001-11-30 2005-06-09 UNIVERSITé LAVAL Milk protein biofilm and uses thereof
US7884068B2 (en) * 2002-03-26 2011-02-08 Assaly Ragheb A Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
US7345150B2 (en) * 2002-03-26 2008-03-18 Medical University Of Toledo Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
ATE466281T1 (de) * 2002-05-07 2010-05-15 Univ New York State Res Found ßHIGH THROUGPUTß METHODE, UM BIOMOLEKÜLANLIEFERUNG FORMULIERUNGEN ZU KENNZEICHNEN
US6770729B2 (en) 2002-09-30 2004-08-03 Medtronic Minimed, Inc. Polymer compositions containing bioactive agents and methods for their use
US20120183593A1 (en) * 2003-04-09 2012-07-19 Directcontact Llc Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US9216106B2 (en) * 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
US20050208102A1 (en) * 2003-04-09 2005-09-22 Schultz Clyde L Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
EP1635782A1 (de) * 2003-05-24 2006-03-22 JUVENA (International) AG Gewebekulturmedien als bestandteil von kosmetika
CA2576040A1 (en) * 2003-10-21 2005-04-28 Bioartificial Gel Technologies Inc. Hydrogel-containing medical articles and methods of using and making the same
ES2332042T3 (es) * 2003-12-18 2010-01-25 Antoine Turzi Hidrogel biorreabsorbible reticulado a base de albumina.
ES2612752T3 (es) 2003-12-18 2017-05-18 Metronom Health, Inc. Biosensor implantable y métodos de uso del mismo
WO2005061018A1 (en) 2003-12-22 2005-07-07 Regentis Biomaterials Ltd. Matrix comprising naturally-occurring protein backbone
US7842667B2 (en) 2003-12-22 2010-11-30 Regentis Biomaterials Ltd. Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
GB0403406D0 (en) * 2004-02-17 2004-03-24 Biotransys Ltd Preparation of carriers for drug delivery and other therapeutic applications
US7351787B2 (en) * 2004-03-05 2008-04-01 Bioartificial Gel Technologies, Inc. Process for the preparation of activated polyethylene glycols
CN101080246A (zh) 2004-04-28 2007-11-28 安希奥设备国际有限责任公司 用于形成交联生物材料的组合物和系统及关联的制备方法与用途
EP1609491B1 (en) 2004-06-16 2008-02-06 Straumann Holding AG Barrier membrane
US7282584B2 (en) 2004-06-16 2007-10-16 Straumann Holding Ag Methylene blue
ES2539969T3 (es) * 2004-08-25 2015-07-07 Essentialis, Inc. Formulaciones farmacéuticas de activadores del canal de potasio de ATP y usos de las mismas
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US8790632B2 (en) * 2004-10-07 2014-07-29 Actamax Surgical Materials, Llc Polymer-based tissue-adhesive form medical use
JP4975627B2 (ja) * 2004-10-07 2012-07-11 アクタマックス サージカル マテリアルズ リミテッド ライアビリティ カンパニー 医療用途のための多糖ベースのポリマー組織接着剤
US20080095911A1 (en) * 2004-12-08 2008-04-24 Sarah Adams Satiety Enhancing Food Product And A Method For Manufacturing Such
WO2006105661A1 (en) * 2005-04-04 2006-10-12 Bioartificial Gel Technologies Inc. Prevention and treatment of radiation dermatitis
EP1865982A1 (en) * 2005-04-06 2007-12-19 Bioartificial Gel Technologies Inc. Hydrogel composition for modulation of topical inflammatory response
US20100215710A1 (en) * 2005-04-08 2010-08-26 The Regents Of The University Of California Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
US8679536B2 (en) * 2005-08-24 2014-03-25 Actamax Surgical Materials, Llc Aldol-crosslinked polymeric hydrogel adhesives
US8679537B2 (en) * 2005-08-24 2014-03-25 Actamaz Surgical Materials, LLC Methods for sealing an orifice in tissue using an aldol-crosslinked polymeric hydrogel adhesive
WO2007059491A2 (en) * 2005-11-14 2007-05-24 University Of Delaware Technology Corporation Novel hydrogels and uses thereof
EP1973525B1 (en) * 2005-12-05 2014-04-30 RBA Pharma Inc. Emulsion-containing medical articles
US20070149916A1 (en) * 2005-12-22 2007-06-28 Alza Corporation Dry matrices as drug reservoirs in electrotransport applications
ATE529113T1 (de) 2006-01-05 2011-11-15 Essentialis Inc Salze von kalium-atp-kanal-öffnern und ihre verwendungen
US8795730B2 (en) * 2006-01-31 2014-08-05 David John Vachon Compositions and methods for promoting the healing of tissue of multicellular organisms
US20080039931A1 (en) * 2006-04-25 2008-02-14 Surmodics, Inc. Hydrophilic shape memory insertable medical articles
US9023114B2 (en) * 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
EP2099845B1 (en) * 2006-11-27 2020-12-23 Actamax Surgical Materials LLC Multi-functional polyalkylene oxides, hydrogels and tissue adhesives
EP2150282B1 (en) * 2007-04-16 2018-04-11 Regentis Biomaterials Ltd. Compositions and methods for scaffold formation
US8092837B2 (en) * 2007-04-27 2012-01-10 Biomet Manufacturing Corp Fibrin based glue with functionalized hydrophilic polymer protein binding agent
CA2692160A1 (en) * 2007-07-02 2009-01-08 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
US20090035249A1 (en) * 2007-08-02 2009-02-05 Bhatia Sujata K Method of inhibiting proliferation of Escherichia coli
EP2214730B1 (en) * 2007-11-14 2014-09-24 Actamax Surgical Materials LLC Dextran-based polymer tissue adhesive for medical use
EP2214731B1 (en) * 2007-11-14 2014-05-14 Actamax Surgical Materials LLC Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US20090220578A1 (en) * 2008-02-28 2009-09-03 Depuy Products, Inc. Hydrogel composition and method for making the same
WO2009117127A2 (en) * 2008-03-19 2009-09-24 University Of Florida Research Foundation, Inc. Nerve repair with a hydrogel and optional adhesive
EP2280739B1 (en) * 2008-06-03 2012-07-04 Actamax Surgical Materials LLC A tissue coating for preventing undesired tissue-to-tissue adhesions
US20100015231A1 (en) * 2008-07-17 2010-01-21 E.I. Du Pont De Nemours And Company Low swell, long-lived hydrogel sealant
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
WO2010059279A2 (en) * 2008-11-19 2010-05-27 E. I. Du Pont De Nemours And Company Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
IL195764A0 (en) 2008-12-07 2009-11-18 Technion Res & Dev Foundation Compositions and methods for drug delivery
US20100160960A1 (en) * 2008-12-19 2010-06-24 E. I. Du Pont De Nemours And Company Hydrogel tissue adhesive having increased degradation time
US8951989B2 (en) 2009-04-09 2015-02-10 Actamax Surgical Materials, Llc Hydrogel tissue adhesive having reduced degradation time
US8580951B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
JP5872463B2 (ja) 2009-07-02 2016-03-01 アクタマックス サージカル マテリアルズ リミテッド ライアビリティカンパニー 医療用ヒドロゲル組織接着剤
US8796242B2 (en) 2009-07-02 2014-08-05 Actamax Surgical Materials, Llc Hydrogel tissue adhesive for medical use
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
WO2011035020A1 (en) * 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
EP2498763A4 (en) 2009-11-09 2015-10-07 Spotlight Technology Partners Llc HYDROGELS BASED ON POLYSACCHARIDE
JP2013509963A (ja) 2009-11-09 2013-03-21 スポットライト テクノロジー パートナーズ エルエルシー 断片化ヒドロゲル
US8828181B2 (en) 2010-04-30 2014-09-09 E I Du Pont De Nemours And Company Temperature switchable adhesives comprising a crystallizable oil
US8409703B2 (en) 2010-07-23 2013-04-02 E I Du Pont De Nemours And Company Temperature switchable adhesive assemblies with temperature non-switchable tack
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
CA2886109A1 (en) * 2012-12-07 2014-06-12 Kansas State University Research Foundation Peptide-albumin hydrogel properties and its applications
WO2015017340A2 (en) 2013-07-29 2015-02-05 Actamax Surgical Materials, Llc Low swell tissue adhesive and sealant formulations
US9512279B2 (en) * 2013-12-18 2016-12-06 Universite Cegy-Pontoise Interpenetrating polymer network
US20160045606A1 (en) * 2014-08-18 2016-02-18 Northwestern University Partially-denatured protein hydrogels
KR102364521B1 (ko) * 2014-09-12 2022-02-17 성균관대학교산학협력단 알부민 및 폴리에틸렌글리콜을 포함하는 하이드로겔 및 그의 제조방법
US20160303281A1 (en) 2015-04-17 2016-10-20 Rochal Industries, Llc Composition and kits for pseudoplastic microgel matrices
US11553879B2 (en) 2015-09-02 2023-01-17 Metronom Health, Inc. Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor
WO2018160696A1 (en) * 2017-03-01 2018-09-07 Metronom Health, Inc. Analyte sensors and methods of manufacturing analyte sensors
US20220088589A1 (en) 2019-01-21 2022-03-24 Eclipse Medcorp, Llc Methods, Systems and Apparatus for Separating Components of a Biological Sample
EP4052034A4 (en) 2019-10-31 2023-12-20 Crown Laboratories, Inc. SYSTEMS, METHODS AND APPARATUS FOR SEPARATING CONSTITUENTS FROM A SAMPLE
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
CN114470310B (zh) * 2021-12-20 2023-03-21 山西医科大学 基于四酶活性纳米酶的自粘性水凝胶及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3463862A (en) * 1964-05-21 1969-08-26 Geneva Carol Mazza Albumin containing comsmetic lotion
US4464468A (en) * 1968-03-29 1984-08-07 Agence Nationale De Valorisation De La Recherche (Anvar) Immobilization of active protein by cross-linking to inactive protein
IL47468A (en) * 1975-06-12 1979-05-31 Rehovot Res Prod Process for the cross-linking of proteins using water soluble cross-linking agents
CH625702A5 (es) * 1977-01-18 1981-10-15 Delalande Sa
US4264155A (en) * 1979-07-09 1981-04-28 Opticol Corporation Collagen contact lens
USRE33997E (en) * 1981-02-09 1992-07-14 Allergan, Inc. Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses
US4388428A (en) * 1981-07-20 1983-06-14 National Patent Development Corporation Biologically stabilized compositions comprising collagen as the major component with ethylenically unsaturated compounds used as contact lenses
FR2565160B1 (fr) * 1984-06-04 1987-03-06 Essilor Int Procede pour la realisation d'une lentille de contact souple en polymere(s) proteique(s) naturel(s), et lentille de contact ainsi obtenue
US4839345A (en) * 1985-03-09 1989-06-13 Nippon Oil And Fats Co., Ltd. Hydrated adhesive gel and method for preparing the same
US4752627A (en) * 1986-08-13 1988-06-21 Michael Froix Clouding-resistant contact lens compositions
US5114627A (en) * 1986-10-16 1992-05-19 Cbs Lens Method for producing a collagen hydrogel
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
FR2617763B1 (fr) * 1987-07-07 1989-12-01 Essilor Int Procede de fabrication de lentille de contact en un polymere proteique naturel, par moulage avant reticulation
US4973466A (en) * 1988-06-21 1990-11-27 Chiron Ophthalmics, Inc. Wound-healing dressings and methods
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5039540A (en) * 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs

Also Published As

Publication number Publication date
PT705298E (pt) 2002-07-31
AU1060495A (en) 1995-06-19
EP0705298B1 (en) 2002-03-27
WO1995015352A1 (en) 1995-06-08
EP0705298A1 (en) 1996-04-10
US5733563A (en) 1998-03-31
ES2172573T3 (es) 2002-10-01
ATE215106T1 (de) 2002-04-15
DE69430243T2 (de) 2002-10-17
DE69430243D1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
DK0705298T3 (da) Albuminbaseret hydrogel
US5529766C1 (en) Contrast agents
ZA9610297B (en) Bioartificial devices and cellular matrices therefor
DK178583A (da) Praeparater med loebende frigoerelse
DE69018769D1 (de) Zur Hautpflege verwendbare Polymermischungen.
ATE105735T1 (de) Immobilisierte polyethylenoxyd-sternmoleküle für bioanwendungen.
SE8405464L (sv) Komposition for oftalmologiska applikationer
DE3687577D1 (de) Nachvernetzte polymerisat-gele.
DK0769056T3 (da) Ikke-splejsende verianter af gp350/220
DK1280849T3 (da) Fremgangsmåde til fremstilling af proteinbaserede hydrogeler
DK0780121T3 (da) Øjendråbepræparat, især til behandling af tørre øjne
CA1186430A (en) Modified synthetic hydrogels
BR9805634A (pt) Hidrogel polimérico para emprego na reparação de defeitos osteocondrais
CA2004871A1 (en) Intraocular hydrogel lens with shape memory